NYSE:NSPR
InspireMD Inc Stock News
$2.12
+0.120 (+6.00%)
At Close: May 06, 2024
InspireMD Announces Planned Leadership Transition
01:00pm, Tuesday, 10'th Dec 2019
InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announced that James Ba
Cloudera and DocuSign Soar, Zoom Video Falls after Earnings
05:42pm, Friday, 06'th Dec 2019
Cloudera announced its earnings for the third quarter of fiscal 2020 on Thursday after the market close. The company reported revenues of $198.3 million.
Edited Transcript of NSPR earnings conference call or presentation 12-Nov-19 1:30pm GMT
04:44am, Wednesday, 04'th Dec 2019
Q3 2019 InspireMD Inc Earnings Call
InspireMD (NSPR) Stock Could Skyrocket Over 370%, Says Analyst
08:42pm, Tuesday, 26'th Nov 2019
Medical device company Inspire MD (NSPR), best known for developing innovative MicroNet technology for vascular procedures, has attracted investor attention today following its release of updated regi
InspireMD Reports Updated Positive CGuard™ EPS Data Presented at VEITH 2019
01:00pm, Tuesday, 26'th Nov 2019
InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today reported on updated registry
InspireMD Offers Updated CGuard Data Presented At VEITH 2019
12:00am, Tuesday, 26'th Nov 2019Is InspireMD, Inc. (NYSEMKT:NSPR) A Volatile Stock?
01:36pm, Wednesday, 13'th Nov 2019
If you own shares in InspireMD, Inc. (NYSEMKT:NSPR) then it's worth thinking about how it contributes to the...
